Kim H, You J, Park E, Kim J
Front Pediatr. 2024; 12:1412400.
PMID: 39403349
PMC: 11471718.
DOI: 10.3389/fped.2024.1412400.
Chesi E, Rossi K, Ancora G, Baraldi C, Corradi M, Di Dio F
PLoS One. 2024; 19(7):e0306769.
PMID: 38980835
PMC: 11233010.
DOI: 10.1371/journal.pone.0306769.
Gulden S, Cervellini G, Colombo M, Marangoni M, Taccani V, Pesenti N
Eur J Pediatr. 2024; 183(9):3809-3818.
PMID: 38877325
DOI: 10.1007/s00431-024-05630-3.
Zamal A, Sk M, Saha B, Hazra A
J Perinatol. 2024; .
PMID: 38609483
DOI: 10.1038/s41372-024-01962-y.
Moronta S, Bischoff A, Ryckman K, Dagle J, Giesinger R, McNamara P
J Perinatol. 2024; 44(3):379-387.
PMID: 38297179
DOI: 10.1038/s41372-024-01883-w.
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Villamor E, van Westering-Kroon E, Gonzalez-Luis G, Bartos F, Abman S, Huizing M
JAMA Netw Open. 2023; 6(11):e2345299.
PMID: 38015504
PMC: 10685885.
DOI: 10.1001/jamanetworkopen.2023.45299.
Effect of different courses and durations of invasive mechanical ventilation on respiratory outcomes in very low birth weight infants.
Yang Y, Gu X, Lin Z, Pan S, Sun J, Cao Y
Sci Rep. 2023; 13(1):18991.
PMID: 37923908
PMC: 10624920.
DOI: 10.1038/s41598-023-46456-7.
The left ventricle in well newborns versus those with perinatal asphyxia, haemodynamically significant ductus arteriosus or fetal growth restriction.
Sehgal A, Menahem S
Transl Pediatr. 2023; 12(9):1735-1743.
PMID: 37814715
PMC: 10560354.
DOI: 10.21037/tp-23-59.
Predictive value of a nomogram model for adverse outcomes in very low birth weight infants with patent ductus arteriosus: A prospective study.
Sun X, Chen L, Gao J
Front Pediatr. 2023; 11:1131129.
PMID: 37114009
PMC: 10126240.
DOI: 10.3389/fped.2023.1131129.
Effectiveness and safety of rectal dexibuprofen versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants with gestational age<34 weeks: A pilot study.
Pan J, Yang Y, Cui S, Chen X, Zhou X
Int J Immunopathol Pharmacol. 2023; 37:3946320231152993.
PMID: 36744872
PMC: 9905032.
DOI: 10.1177/03946320231152993.
Reference Values for Point-of-Care Echocardiographic Measurements of Preterm Infants in China.
Lu D, Tong X, Liu Y, Zhang H
Front Pediatr. 2022; 10:894152.
PMID: 35844737
PMC: 9280336.
DOI: 10.3389/fped.2022.894152.
Patent ductus arteriosus and spontaneous intestinal perforation in a cohort of preterm infants.
Mayer A, Francescato G, Pesenti N, Schena F, Mosca F
J Perinatol. 2022; 42(12):1649-1653.
PMID: 35589970
DOI: 10.1038/s41372-022-01403-8.
Oral Versus Intravenous Medications for Treatment of Patent Ductus Arteriosus in Preterm Neonates: A Cost-Saving Initiative.
Godin R, Rodriguez J, Kahn D
J Pediatr Pharmacol Ther. 2021; 26(3):291-299.
PMID: 33833632
PMC: 8021241.
DOI: 10.5863/1551-6776-26.3.291.
Management of Patent Ductus Arteriosus in Premature Infants in 2020.
Parkerson S, Philip R, Talati A, Sathanandam S
Front Pediatr. 2021; 8:590578.
PMID: 33643964
PMC: 7904697.
DOI: 10.3389/fped.2020.590578.
Predictive Value of Blood N-Terminal Pro-Brain Natriuretic Peptide Concentrations for Early Patent Ductus Closure in Very Preterm Infants.
Potsiurko S, Dobryanskyy D, Sekretar L
J Saudi Heart Assoc. 2021; 32(4):462-470.
PMID: 33537192
PMC: 7849842.
DOI: 10.37616/2212-5043.1230.
Early Role of the Atrial-Level Communication in Premature Infants with Patent Ductus Arteriosus.
Rios D, Martins F, El-Khuffash A, Weisz D, Giesinger R, McNamara P
J Am Soc Echocardiogr. 2020; 34(4):423-432.e1.
PMID: 33227390
PMC: 8026594.
DOI: 10.1016/j.echo.2020.11.008.
Initial Experience With Patent Ductus Arteriosus Ligation in Pre-term Infants With Bidirectional Shunt Pattern.
Yang M, Liu H, Wu H, Tey S, Yang Y, Wu C
Front Pediatr. 2020; 8:591441.
PMID: 33194925
PMC: 7649389.
DOI: 10.3389/fped.2020.591441.
[B-type brain natriuretic peptide as marker of hemodynamic overload of the patent ductus arteriosus in the preterm infant].
Parra-Bravo J, Valdovinos-Ponce M, Garcia H, Nunez-Enriquez J, Jimenez-Cardenas M, Aviles-Monjaraz R
Arch Cardiol Mex. 2020; 91(1):17-24.
PMID: 33142312
PMC: 8258918.
DOI: 10.24875/ACM.19000398.
Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
Gupta B, Saha A, Mukherjee S, Saha B
Eur J Pediatr. 2020; 179(8):1287-1293.
PMID: 32462483
PMC: 7251045.
DOI: 10.1007/s00431-020-03682-9.
Plasma B-type natriuretic peptide cannot predict treatment response to ibuprofen in preterm infants with patent ductus arteriosus.
Oh S, Lee B, Jung E, Oh M, Do H, Kim E
Sci Rep. 2020; 10(1):4430.
PMID: 32157119
PMC: 7064477.
DOI: 10.1038/s41598-020-61291-w.